Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Vera Sylvia Castanho is active.

Publication


Featured researches published by Vera Sylvia Castanho.


BMC Public Health | 2001

Sex differences in risk factors for coronary heart disease: a study in a Brazilian population

Vera Sylvia Castanho; Letícia S Oliveira; Hildete Prisco Pinheiro; Helena C. F. Oliveira; Eliana Cotta de Faria

BackgroundIn Brazil coronary heart disease (CHD) constitutes the most important cause of death in both sexes in all the regions of the country and interestingly, the difference between the sexes in the CHD mortality rates is one of the smallest in the world because of high rates among women. Since a question has been raised about whether or how the incidence of several CHD risk factors differs between the sexes in Brazil the prevalence of various risk factors for CHD such as high blood cholesterol, diabetes mellitus, hypertension, obesity, sedentary lifestyle and cigarette smoking was compared between the sexes in a Brazilian population; also the relationships between blood cholesterol and the other risk factors were evaluated.ResultsThe population presented high frequencies of all the risk factors evaluated. High blood cholesterol (CHOL) and hypertension were more prevalent among women as compared to men. Hypertension, diabetes and smoking showed equal or higher prevalence in women in pre-menopausal ages as compared to men. Obesity and physical inactivity were equally prevalent in both sexes respectively in the postmenopausal age group and at all ages. CHOL was associated with BMI, sex, age, hypertension and physical inactivity.ConclusionsIn this population the high prevalence of the CHD risk factors indicated that there is an urgent need for its control; the higher or equal prevalences of several risk factors in women could in part explain the high rates of mortality from CHD in females as compared to males.


Arquivos Brasileiros De Cardiologia | 2012

Tratamento pós-menopausa reduz a atividade da catalase e atenua o risco cardiovascular

Vera Sylvia Castanho; Rui T. Nakamura; Aarão Mendes Pinto-Neto; Eliana Cotta de Faria

BACKGROUND: Menopause can lead to alterations in womens health, with changes in the oxidative status of postmenopausal women in whom information regarding the influence of hormone therapy (HT) on antioxidant enzyme activities is limited. OBJECTIVE: To evaluate the influence of HT on catalase activity; concentrations of lipids and lipoprotein, cholesteryl ester transfer protein, thiobarbituric acid-reactive substances, nitrates, high-sensitivity C-reactive protein and carotid thickness in postmenopausal women. METHODS: Ninety-four consecutive women were allocated to one of four groups, without HT and with HT. The latter group was subdivided into women using estrogen and those using estrogen plus progestogen therapy. Plasma biochemical parameters and common carotid intima-media thickness measurements were performed. RESULTS: HT antagonized the decrease in catalase activity after menopause, but had no effect on the levels of cholesteryl ester transfer protein, thiobarbituric acid-reactive substances, lipid peroxide, nitrate, high-sensitivity C-reactive protein, or on the common carotid intima-media thickness. Multivariate analysis showed that estrogen-based HT attenuated the relationship between cardiovascular risk factors and the intima-media thickness of the common carotid. CONCLUSION: This study indicates that HT in postmenopausal women produces beneficial antioxidant and anti-atherosclerotic effects by ameliorating the plasma lipid and lipoprotein profiles, increasing plasma catalase activity and attenuating the association between cardiovascular risk factors and early atherosclerosis.


Jornal Brasileiro De Patologia E Medicina Laboratorial | 2013

Development of a clinical laboratory data base of hyper and hypo alpha lipoproteins in Campinas-SP and neighboring region

Eliane Soler Parra; Vanessa Helena de Souza Zago; N.B. Panzoldo; Fernanda Alexandre; Felipe Vendrame; Vitor W.M. Virginio; Isabela Calanca Vieira; Marcelo Scarpari Dutra Rodrigues; Angela de Souza Cassol; Fabio Luiz D'Alexandri; Vera Sylvia Castanho; Rui T. Nakamura; Jamal Baracat; Mirian Regina Gardin Danelon; Ronise Carla Sass Pozeti; Ana Cândida Coutinho Facin; Hilda Maria da Silva Honorio; Simone de Cássia Dias Mesquita; Marcio Jorge da Silva; Marielza Crosgnac Feres Lot; V.S. Nunes; Camila Canteiro Leança; Edna R. Nakandakare; Eder C.R. Quintão; Eliana Cotta de Faria

INTRODUCTION: The development of research for diagnosis, prevention and treatment of atherosclerotic cardiovascular disease is of utmost importance due to the fact that it is the main cause of morbidity and mortality in Brazil. OBJECTIVE: To demonstrate the phases of the selection process for candidates with the aim to develop a clinical-laboratorial database of hyper alpha lipoproteinemic patients (hyper A) - high density lipoprotein cholesterol (HDL-C) ≥ 68 mg/dl) and hypo alpha lipoproteinemic patients (hypo A) - HDL-C < 39 mg/dl. MATERIAL AND METHODS: The volunteers were contacted after selection of lipid profiles from individuals treated at the Sistema Unico de Saude (SUS), Campinas-SP and neighboring area. Afterwards, the selected patients went through blood collection, clinical examinations and answered questionnaires on dietary frequency and physical activity. After this preliminary evaluation, some individuals were convened to another blood collection and, subsequently, were submitted to an ultrasonographic exam of the carotid arteries. RESULTS: Only 0.6% and 0.3% from 598,288 lipid profiles were selected for hyper A and hypo A groups, respectively, including gender disparity. Lack of effective questionnaires (75%), missing calls (60%) and non-inclusion were the major hindrances in the construction of this database. DISCUSSION: The difficulties to obtain eligible candidates were also due to the low prevalence of both groups hypo A and hyper A and the high prevalence of pathologies that contribute to non-genetic variations of HDL-C. CONCLUSION: In spite of the obstacles in the development of this database, this study brought about several scientific publications. Furthermore, the development of molecular analyzes and functionality will shortly generate other findings, contributing to the diagnosis and follow-up of HDL dyslipidemias.


Gynecological Endocrinology | 2011

Post-menopausal hormone therapy reduces autoantibodies to oxidized apolipoprotein B100

Vera Sylvia Castanho; Magnus Gidlund; Rui T. Nakamura; Eliana Cotta de Faria

The aim of the study was to verify whether post-menopausal hormone replacement therapy (HRT) modifies autoantibody titers against oxidized low-density lipoprotein (LDL) (anti-LDLoxi), against epitopes of oxidized apolipoprotein B100 and common carotid intima-media thickness (IMT) in these women. Sixty-eight women in pre-menopause (PMW) and 216 in post-menopause (POMW) were recruited; eighty-three had undergone HRT for at least 12 months, where 48 received conjugated estrogens alone (EHRT) and 35 received conjugated estrogen and medroxyprogesterone acetate (CHRT). ELISA was used to determine autoantibodies. Lipoprotein lipase (LPL), hepatic lipase (HL), cholesterol ester transfer protein (CETP) and phospholipid transfer protein (PLTP) activities were assayed by radiometric methods. IMT was measured using Doppler ultrasound. Anti-oxidized LDL and anti-D antibodies increased by 40% (p ≤ 0.003) and 42% (p ≤ 0.006), respectively, with menopause. There was a surprising and significant 7% reduction in anti-D2 antibody titers with HRT (p ≤ 0.050), indicating a positive effect of treatment on the immune response to oxidized LDL. Combined HRT decreased activities of HL and LPL. HRT did not change common carotid IMT, which was increased by 32% as expected after menopause (p ≤ 0.030). This study describes, for the first time, the protective effect of HRT on decreasing autoantibody titers against oxidized apolipoprotein B in LDL.


Revista De Nutricao-brazilian Journal of Nutrition | 2013

Lipid and lipoprotein responses of dyslipidemic patients to exclusive nutritional counseling by gender and age

Harumi Kinchoku; Vera Sylvia Castanho; Mirian Regina Gardin Danelon; Eliana Cotta de Faria

OBJECTIVE: The aim of the present study was to evaluate the plasma lipid responses of dyslipidemic patients to nutritional counseling according to gender and age. METHODS: One-hundred and twenty nine dyslipidemic subjects comprised the study, 56 men and 73 women, aged 20 to 73 years, treated at the Dyslipidemia Outpatient Clinic of the Universidade Estadual de Campinas Clinic Hospital. The inclusion criteria established that no lipid-lowering medication had been used in the 30 days prior to and during the nutritional counseling. Blood samples were collected in the morning after a 12 hour fast. The participants were divided into groups according to gender and age (age 60 years). The hypercholesterolemic patients were instructed to restrict saturated fats ( 300mg/dL) were asked to consume a low fat diet. Those with mixed hyperlipidemia were instructed to do both. Statistical analyses included the Wilcoxon, Mann-Whitney, Chi-square and Fishers exact tests and Analysis of Covariance. RESULTS: After nutritional counseling, total cholesterol and triglycerides decreased by 16% and 36% in males, and by 12% and 26% in females, respectively, and Low Density Lipoprotein-cholesterol decreased by 12% in females. Only triglycerides decrease significantly. In the mixed hyperlipidemia group, the male and female triglyceride (-44% and -29%), Low Density Lipoprotein-cholesterol (+12% and -15%) and High Density Lipoprotein-cholesterol (+7% and -3%) levels differed significantly. Between the age groups, only triglyceride levels differed significantly, with adults experiencing the highest reductions (33%). CONCLUSION: Nutritional counseling effectively lowered plasma lipid and lipoprotein levels, reinforcing the benefits of dietary interventions for the treatment of dyslipidemia.


Journal of Clinical Laboratory Analysis | 2006

High‐density lipoprotein subfractions in normolipidemic individuals without clinical atherosclerosis lipoprotein subfractions in an adult population

Fabio L. Sodré; Vera Sylvia Castanho; L.N. Castilho; Sílvia de Barros-Mazon; Eliana Cotta de Faria


Revista Argentina de Endocrinología y Metabolismo | 2013

Early Carotid Atherosclerosis and Hepatic Lipase-514 C/T Polymorphism: A Study in Hyperalphalipoproteinemic Individuals

Fernanda Dutra Santiago; Roberto Schreiber; N.B. Panzoldo; R.T. Nakamura; Eliane Soler Parra; Vanessa Helena de Souza Zago; L Bertholo; Vera Sylvia Castanho; M.N Danelon; Eder C.R. Quintao; E.C de Faria


Revista Argentina de Endocrinología y Metabolismo | 2013

Aterosclerosis carotídea subclínica y el polimorfsmo HL-514 C/T de la lipasa hepática: un estudio en individuos hiperalfalipoproteinémicos

Fernanda Dutra Santiago; Roberto Schreiber; N.B. Panzoldo; R.T. Nakamura; Eliane Soler Parra; Vanessa Helena de Souza Zago; L Bertholo; Vera Sylvia Castanho; M.N Danelon; Eder C.R. Quintao; E.C de Faria


Archive | 2012

Tratamento Pós-Menopausa Reduz a Atividade da Catalase e Atenua o Risco Cardiovascular Postmenopausal Therapy Reduces Catalase Activity and Attenuates Cardiovascular Risk

Vera Sylvia Castanho; Rui T. Nakamura; Aarão Mendes Pinto-Neto; Eliana Cotta de Faria


Atherosclerosis Supplements | 2009

Abstract: 1058 IMPROVED CATALASE ACTIVITY AND CAROTID INTIMA-MEDIA THICKNESS MODULATION WITH POSTMENOPAUSAL THERAPY

Vera Sylvia Castanho; I.F. Espirito Santo; R.T. Nakamura; E.C. de Faria

Collaboration


Dive into the Vera Sylvia Castanho's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Rui T. Nakamura

State University of Campinas

View shared research outputs
Top Co-Authors

Avatar

Eliane Soler Parra

State University of Campinas

View shared research outputs
Top Co-Authors

Avatar

N.B. Panzoldo

State University of Campinas

View shared research outputs
Top Co-Authors

Avatar

R.T. Nakamura

State University of Campinas

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

E.C. de Faria

State University of Campinas

View shared research outputs
Top Co-Authors

Avatar

Eder C.R. Quintao

State University of Campinas

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge